Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 July, 2018 21:11 IST
Zydus Cadila gets Mexican regulatory authority's nod for Lipaglyn
Source: IRIS | 13 Nov, 2017, 11.41AM
Comments  |  Post Comment

Zydus announced that the Mexico regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval to commercialize Lipaglyn™ (Saroglitazar Magnesium) in Mexico for the treatment of Dyslipidemia in patients with diabetes mellitus type 2 and Hypertriglyceridemia in patients with diabetes mellitus type 2 not controlled by statins.
 
Elevated triglycerides and insulin resistance are two key components of the metabolic syndrome, which medical science believes are responsible for diseases like hypertriglyceridemia, diabetic dyslipidemia or Non-Alcoholic Steatohepatitis disease (NASH). Increased triglyceride accumulation in the liver can also lead to inflammation, fibrosis, cirrhosis and liver failure, a serious medical condition known as NAFLD or NASH. Additionally, Zydus is currently evaluating Saroglitazar in several clinical trials for treating liver conditions like NASH and Primary Biliary Cholangitis (PBC).
 
''Saroglitazar is an important scientific and medical breakthrough in our effort to develop medicines for patients suffering from hypertriglyceridemia and diabetic dyslipidemia,'' said Pankaj Patel, Chairman, Zydus Group, and added, ''This approval of Saroglitazar in Mexico is a major milestone for the company.''

Shares of the company declined Rs 27.65, or 5.78%, to trade at Rs 451.00. The total volume of shares traded was 51,256 at the BSE (11.17 a.m., Monday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Wipro Q1 earnings rise 16.3% q-o-q to Rs 20.93 bn - 20-Jul-2018 16:53
PNC Infratech receives LOI for Purvanchal Expressway EPC Projects - 20-Jul-2018 15:52
Himachal Futuristic Communications receives orders worth Rs 20.04 bn - 20-Jul-2018 15:45
Zydus Cadila gets final nod for Spironolactone tablets - 20-Jul-2018 15:40
Bank of Baroda signs MoU with 10 companies - 20-Jul-2018 15:34
NCLT approves JK Paper's Rs 3.71 bn bid for Sirpur Paper Mills - 20-Jul-2018 13:40
Global oil brand ECSTAR now at Maruti Suzuki ARENA network - 20-Jul-2018 10:23
Gayatri Projects wins two road contracts worth Rs 27.59 bn - 20-Jul-2018 09:58
Jain Irrigation Systems bags project worth Rs 9.75 bn - 20-Jul-2018 09:53
Yes Bank partners with 10 smart cities to tackle development challenges - 19-Jul-2018 17:36
Govt to infuse capital worth Rs 17.9 bn in Allahabad Bank - 19-Jul-2018 16:17
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer